Prostate Cancer

Prognostic Value of LuPSMA-SPECT/CT: Developing Clinical Protocols for Monitoring mCRPC Therapy
Dr. Loïc Djaileb explores the use of RECIP 1.0 criteria with SPECT/CT and the efficacy of this strategy in monitoring mCRPC.
Advertisement

Latest News

Prostate Cancer Knowledge Hubs

Curated clinical content on prostate cancer types, therapies, and technologies

Advertisement

Conference Coverage

Advertisement
Advertisement
Trending